In March, the Swiss pharmaceutical company Novartis settled an FCPA enforcement action brought by the SEC for $25 million. As noted in the Cease and Desist Order,

In March, the Swiss pharmaceutical company Novartis settled an FCPA enforcement action brought by the SEC for $25 million. As noted in the Cease and Desist Order,
Thomas Fox has practiced law for over 40 years. Tom writes the daily award-winning blog, the FCPA Compliance and Ethics blog and founded the Compliance Podcast Network. Tom leads the discussion on AI in... More by Tom Fox